GLP-1 Analogue and Medication Review Optimisation

Practice Pro-Forma

In response to the national shortage of GLP-1 analogues, ECLIPSE (Equality of Care Led Insights for Patient Safety & Engagement), in collaboration with your ICB and PCN, is implementing a GLP-1 and medicines optimisation project, which aims to engage with patients on GLP-1 analogues, to:

  • Identify those with a genuine indication or need for this class of medication.

  • Where indicated, to ensure that patients have adequate supply of their GLP-1 analogues.

  • Evaluate patients for which GLP-1s may no longer be indicated, or where they could safely move to an alternative medication.

  • Obtain patient consent to consider stopping or changing their GLP-1 medication.

  • To provide significant cost-savings to the NHS.

This pathway aims to gather important patient information around their diabetes management, empower patient-led care while safely addressing the national medication shortage.

Additionally, the CQC-accredited Putting Patient's First team will use this opportunity to conduct holistic structured medication reviews to optimise patient safety through appropriate and agreed medication changes and maximise cost-savings to the region.

Please complete the pro forma below to provide practice consent for this programme.